Related Experiment Video

Updated: May 9, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

Hypertension, fluid overload and micro inflammation are associated with left ventricular hypertrophy in maintenance

Yan Xu1, Yue Chen, Daming Li

  • 1Department of Nephrology, Tongji Hospital, Tongji University , Shanghai , China.

Renal Failure
|August 2, 2013
PubMed

Insights

This study identified key risk factors for left ventricular hypertrophy (LVH) in hemodialysis patients. High blood pressure, NT-proBNP, and hs-CRP are independently associated with LVH, highlighting the role of hypertension and inflammation.

Area of Science:

  • Nephrology
  • Cardiology
  • Biomedical Science

Background:

  • Left ventricular hypertrophy (LVH) is a common complication in patients undergoing maintenance hemodialysis (HD).
  • Identifying risk factors for LVH is crucial for improving cardiovascular outcomes in this high-risk population.

Purpose of the Study:

  • To investigate the potential risk factors associated with left ventricular hypertrophy (LVH) in patients receiving maintenance hemodialysis.
  • To determine the independent predictors of LVH using univariate and multivariate analyses.

Main Methods:

  • Cross-sectional study involving 112 hemodialysis patients.
  • Data collection included echocardiography, anthropometric measurements, and biochemical analyses.
  • Statistical analyses comprised univariate analysis, linear regression, binary logistic regression, and ROC curve analysis.

Main Results:

  • Systolic blood pressure, amino-terminal pro-B-natriuretic peptide (NT-proBNP), and left ventricular ejection fraction (LVEF) were independently associated with left ventricular mass index (LVMI).
  • Higher systolic blood pressure, NT-proBNP, and high-sensitivity C-reactive protein (hs-CRP) showed an independent correlation with LVH.
  • NT-proBNP demonstrated a stronger association with LVH compared to hs-CRP and cardiac troponin T (cTnT) based on ROC analysis.

Conclusions:

  • Hypertension, fluid overload, and micro-inflammation are significant contributors to LVH in maintenance HD patients.
  • Both traditional and non-traditional risk factors play a critical role in the development of LVH.
  • NT-proBNP is a valuable biomarker for assessing LVH risk in hemodialysis patients.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...